Meeder Asset Management Inc Royalty Pharma PLC Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$27.46 - $31.33 $5,601 - $6,391	204 New	204 $6,000
Q1 2022 May 10, 2022	SELL	$37.46 - $42.44 $149 - $169	-4 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$35.17 - $42.48 $515,838 - $623,054	-14,667 Reduced 99.97%	4 $0
Q3 2021 Nov 08, 2021	SELL	$36.14 - $42.24 $73,291 - $85,662	-2,028 Reduced 12.14%	14,671 $531,000
Q2 2021 Aug 09, 2021	SELL	$39.85 - $46.63 $2,749 - $3,217	-69 Reduced 0.41%	16,699 $684,000
Q1 2021 Apr 28, 2021	BUY	$42.34 - $52.82 $709,957 - $885,685	16,768 New	16,768 $731,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.